The role of the DDAH-ADMA pathway in the protective effect of resveratrol analog BTM-0512 on gastric mucosal injury

Canadian Journal of Physiology and Pharmacology

Volumn 88, Issue 5, 2010, Pages 562-567

  Li, Li ^a   Luo, Xiu Ju ^a   Liu, Ying Zi ^b   Zhang, Yi Shuai ^a   Yuan, Qiong ^a   Tan, Na ^a   Xiang, Da Xiong ^c   Peng, Jun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN NORMAL UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asymmetric dimethylarginine (ADMA); Dimethylarginine dimethylaminohydrolase (DDAH); Gastric ulcer; Resveratrol; Trans 3,5,4 trimethoxystilbene (BTM 0512)

Indexed keywords

ALCOHOL; ARGININE; BTM 0512; DIMETHYLARGININASE; HYDROXYL RADICAL; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; RESVERATROL; SUPEROXIDE; TRANS 3,5,4' TRIMETHOXYSTILBENE; UNCLASSIFIED DRUG; 3,4',5-TRIMETHOXYSTILBENE; AMIDASE; ANTIULCER AGENT; N,N-DIMETHYLARGININE; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH; STOMACH INJURY; STOMACH MUCOSA; STOMACH PROTECTION; STOMACH ULCER; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICAL STRUCTURE; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; ENZYMOLOGY; METABOLISM; SPRAGUE DAWLEY RAT; TOXICITY;

AMIDOHYDROLASES; ANIMALS; ANTI-ULCER AGENTS; ARGININE; DISEASE MODELS, ANIMAL; ETHANOL; HYDROXYL RADICAL; MALE; MOLECULAR STRUCTURE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; STOMACH ULCER; SUPEROXIDES;

EID: 77952893319     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y10-027     Document Type: Article

References (24)

1. Berg, A., Redeen, S., Ericson, A.C., and Sjöstrand, S.E. 2004. Nitric oxide: an endogenous inhibitor of gastric acid secretion in isolated human gastric glands. BMC Gastroenterol. 4(1): 16. doi:10.1186/1471-230X-4-16. PMID:15298720. (Pubitemid 39637360)
2. Böger, R.H. 2003. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc. Res. 59(4): 824-833. doi:10.1016/S0008-6363(03)00500-5. PMID: 14553822.
3. Dayoub, H., Achan, V., Adimoolam, S., Jacobi, J., Stuehlinger, M.C., Wang, B.Y., et al. 2003. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation, 108(24): 3042-3047. doi:10.1161/01.CIR.0000101924.04515.2E. PMID:14638548. (Pubitemid 37553576)
4. Dey, A., Guha, P., Chattopadhyay, S., and Bandyopadhyay, S.K. 2009. Biphasic activity of resveratrol on indomethacin-induced gastric ulcers. Biochem. Biophys. Res. Commun. 381(1): 90-95. doi:10.1016/j.bbrc.2009.02.027. PMID:19351601.
5. Duffin, R., Shaw, C.A., and Rossi, A.G. 2008. Sildenafil reduces alcohol-induced gastric damage: just say "NO". Br. J. Pharmacol. 153(4): 623-624. doi:10.1038/sj.bjp.0707642. PMID: 18084311.
6. Feng, Q., Lu, X., Jones, D.L., Shen, J., and Arnold, J.M. 2001. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation, 104(6): 700-704. doi:10.1161/hc3201.092284. PMID:11489778. (Pubitemid 32738526)
7. Goso, Y., Ueno, M., Hotta, K., and Ishihara, K. 2007. Protective effects of the whisky congeners on ethanol-induced gastric mucosal damage. Alcohol. Clin. Exp. Res. 31(3): 390-394. doi:10.1111/j.1530-0277.2006.00319.x. PMID:17295722.
8. Guha, P., Dey, A., Sarkar, B., Dhyani, M.V., Chattopadhyay, S., and Bandyopadhyay, S.K. 2009. Improved antiulcer and anticancer properties of a trans-resveratrol analog in mice. J. Pharmacol. Exp. Ther. 328(3): 829-838. doi:10.1124/jpet.108.145334. PMID:19066340.
9. Guth, P.H., Aures, D., and Paulsen, G. 1979. Topical aspirin plus HCl gastric lesions in the rat. Cytoprotective effect of prostaglandin, cimetidine, and probanthine. Gastroenterology, 76(1): 88-93. PMID:361495.
10. Khattab, M.M., Gad, M.Z., and Abdallah, D. 2001. Protective role of nitric oxide in indomethacin-induced gastric ulceration by a mechanism independent of gastric acid secretion. Pharmacol. Res. 43(5): 463-467. doi:10.1006/phrs.2001.0801. PMID: 11394938.
11. Klinge, C.M., Wickramasinghe, N.S., Ivanova, M.M., and Dougherty, S.M. 2008. Resveratrol stimulates nitric oxide production by increasing estrogen receptor α-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J. 22(7): 2185-2197. doi:10.1096/fj.07-103366. PMID:18296501.
12. Lanas, A. 2008. Role of nitric oxide in the gastrointestinal tract. Arthritis Res. Ther. 10(Suppl. 2): S4. doi:10.1186/ar2465. PMID:19007429.
13. Liu, Y.Z., Zhou, Y., Li, D., Wang, L., Hu, G.Y., Peng, J., and Li, Y.J. 2008. Reduction of asymmetric dimethylarginine in the protective effects of rutaecarpine on gastric mucosal injury. Can. J. Physiol. Pharmacol. 86(10): 675-681. doi:10.1139/Y08-073. PMID:18841172.
14. Ma, N., Li, H.D., Liu, W.Y., Jiang, X.Y., Zhang, B.K., and Xiang, D.X. 2008. Pharmacokinetic studies resveratrol derivative (BTM-0512) in rat plasma. Chin. J. Pharmacol. Anal. 28: 1413-1417.
15. Martin, G.R., and Wallace, J.L. 2006. Gastrointestinal inflammation: a central component of mucosal defense and repair. Exp. Biol. Med. 231(2): 130-137. PMID:16446488.
16. Opie, L.H., and Lecour, S. 2007. The red wine hypothesis: from concepts to protective signalling molecules. Eur. Heart J. 28(14): 1683-1693. doi:10.1093/eurheartj/ehm149. PMID: 17561496.
17. Penumathsa, S.V., and Maulik, N. 2009. Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease. Can. J. Physiol. Pharmacol. 87(4): 275-286. doi:10.1139/Y09-013. PMID:19370081.
18. Sakurada, M., Shichiri, M., Imamura, M., Azuma, H., and Hirata, Y. 2008. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells. Hypertension, 52(5): 903-909. doi:10.1161/HYPERTENSIONAHA.108.114207. PMID:18824664.
19. Thirunavukkarasu, M., Penumathsa, S.V., Koneru, S., Juhasz, B., Zhan, L., Otani, H., et al. 2007. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic. Biol. Med. 43(5): 720-729. doi:10.1016/j.freeradbiomed. 2007.05.004. PMID:17664136.
20. Tran, C.T., Leiper, J.M., and Vallance, P. 2003. The DDAH/ADMA/NOS pathway. Atheroscler. Suppl. 4(4): 33-40. doi:10.1016/S1567-5688(03)00032-1. PMID:14664901.
21. Wallace, J.L. 2006. Nitric oxide, aspirin-triggered lipoxins and NO-aspirin in gastric protection. Inflamm. Allergy Drug Targets, 5(2): 133-137. doi:10.2174/187152806776383116. PMID: 16613572.
22. Wang, L., Zhou, Y., Peng, J., Zhang, Z., Jiang, D.J., and Li, Y.J. 2008. Role of endogenous nitric oxide synthase inhibitor in gastric mucosal injury. Can. J. Physiol. Pharmacol. 86(3): 97-104. doi:10.1139/Y08-003. PMID:18418436.
23. Wojciak-Stothard, B., Torondel, B., Zhao, L., Renné, T., and Leiper, J.M. 2009. Modulation of Rac1 activity by ADMA/DDAH regulates pulmonary endothelial barrier function. Mol. Biol. Cell, 20(1): 33-42. doi:10.1091/mbc.E08-04-0395. PMID: 18923147.
24. Young, J.M., Terrin, N., Wang, X., Greene, T., Beck, G.J., Kusek, J.W., et al. 2009. Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease. Clin. J. Am. Soc. Nephrol. 4(6): 1115-1120. doi:10.2215/CJN. 06671208. PMID:19389824.